TABLE 1.

99mTc-Pyrophosphate Cardiac Amyloidosis Imaging Parameters

ParameterCharacteristicsStandard/optional/preferred
Camera typeLarge-field-of-view γ-cameraStandard
Cadmium zinc tellurideOptional*
Energy peak140 keVStandard
Energy window15%–20%Standard
CollimatorLow-energy, all-purposeStandard
Patient positionSupineStandard
Field of viewHeart/chestStandard
Injection-to-imaging time3 hStandard
1 hOptional
Planar
 Acquisition typeStaticStandard
Whole-body imagingOptional
 Detector configuration90°Standard
 ViewsAnterior and left lateralStandard
 Number of views2Standard
 Counts per view750,000Standard
 Matrix256 × 256Standard
 Magnification1.46
SPECT or SPECT/CT*
 Acquisition typeStep and shoot or continuousStandard
 Patient positionSupineStandard
UprightOptional
 Orbit180°/90°Standard
360°/180°Optional
 Matrix128 × 128 (minimum, 64 × 64)Standard
 Magnification1.46 (180° orbit)Standard
1.0 (360° orbit)Optional
 Pixel size2.3–6.5 mmStandard
 Projections per detector40/32Standard
 Time per projection20 s/25 sStandard
 CT attenuation correctionHeartPreferred
  • * Parameters defined for γ-cameras as parameters for cadmium-zinc-telluride cameras have not been firmly established.

  • Whole-body imaging is not useful when imaging with 99mTc-pyrophosphate. However, when using 99mTc-hydroxymethylenediphosphonate or 99mTc-DPD, whole-body imaging is useful to demonstrate soft-tissue uptake.